Today: 30 April 2026

Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Pfizer shares fell 0.6% to $25.12 in Tuesday afternoon trading after CEO Albert Bourla discussed plans to accelerate obesity drug trials at the J.P. Morgan Healthcare Conference. Bourla said Pfizer aims to launch 10 Phase 3 trials for its Metsera portfolio by 2026 but does not expect revenue growth before 2029. Investors await the Feb. 3 earnings report for updates on the obesity pipeline and guidance.
13 January 2026
···
Wall Street slips on JPMorgan warning as December inflation holds at 2.7% — Visa, Mastercard tumble

Wall Street slips on JPMorgan warning as December inflation holds at 2.7% — Visa, Mastercard tumble

U.S. stocks fell Tuesday, with the Dow down 338 points, as financials slumped after JPMorgan warned a proposed credit-card rate cap could hurt consumers. Visa dropped 4.7% and Mastercard lost 5.3%. December CPI rose 0.3%, annual inflation held at 2.7%, and core inflation ran at 2.6%. Traders still expect at least two Fed rate cuts later this year.
13 January 2026
····
SoFi stock rises as Trump’s 10% credit-card cap idea shakes lenders — what investors watch next

SoFi stock rises as Trump’s 10% credit-card cap idea shakes lenders — what investors watch next

SoFi shares rose 1.1% to $26.89 Tuesday afternoon, outperforming a 0.4% drop in the S&P 500 as investors assessed Trump’s proposed 10% cap on credit card interest rates. The policy push has rattled banks and payments firms, who warn it could restrict credit. Wall Street analysts see legal hurdles but say fintech lenders like SoFi could benefit if banks tighten lending. Focus turns to SoFi’s Jan. 30 earnings.
13 January 2026
·
ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow shares fell 3.3% to $137.95 Tuesday after Oppenheimer cut its price target to $200, citing sector concerns ahead of earnings. Goldman Sachs began coverage with a Buy rating and $205 target, while Citi maintained its Buy and placed the stock on a 30-day catalyst watch. The iShares Expanded Tech-Software ETF dropped 2%. Investors remain cautious after ServiceNow’s $7.75 billion Armis acquisition.
13 January 2026
··
Ofwat warns on South East Water outage as Severn Trent, United Utilities shares fall

Ofwat warns on South East Water outage as Severn Trent, United Utilities shares fall

Around 25,000 homes in Kent and Sussex lost water after a new supply failure at South East Water, prompting Ofwat to flag concern and launch a review. Shares in Severn Trent, United Utilities, and Pennon fell up to 2.6% as scrutiny intensified. South East Water is using tankers and bottled-water stations while restoring pressure, with full service expected by Wednesday. Some homes have faced four days without water.
13 January 2026
···
AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie shares fell 0.1% to $219.83 Tuesday after announcing a three-year U.S. pricing deal tied to tariff exemptions. The company also signed a $650 million licensing agreement with China’s RemeGen for rights to an experimental cancer drug and bought a manufacturing site in Arizona. Management is set to speak at the J.P. Morgan Healthcare Conference on Jan. 14.
13 January 2026
··
Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam shares fell 0.1% to $370.39 Tuesday afternoon after the company projected 2026 net product revenue between $4.9 billion and $5.3 billion. Preliminary 2025 sales were disclosed at $2.987 billion. Analysts remained mostly positive but flagged possible weakness for Amvuttra next quarter. The update came as Alnylam outlined its new five-year strategy at the J.P. Morgan Healthcare Conference.
13 January 2026
··
Ingenico’s WalletConnect tie-up brings stablecoin payments to in-store checkout

Ingenico’s WalletConnect tie-up brings stablecoin payments to in-store checkout

Ingenico said Tuesday it will enable stablecoin payments at checkout counters using WalletConnect Pay on its Android point-of-sale terminals. The feature will support five stablecoins and over 700 wallets, with fees expected below those of traditional card payments. Ingenico’s terminals operate in 120 countries, but the company did not say how many merchants will adopt the option immediately.
13 January 2026
····
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals shares fell 10.6% after the FDA extended its review of partner Travere’s Filspari label expansion, resetting the decision deadline to April 13. Travere shares dropped 19%. The FDA classified the latest filing as a “major amendment” but did not request new safety or manufacturing data. The broader biotech sector was little changed.
13 January 2026
···
Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola shares rose 0.5% to $70.83 Tuesday after the company set Feb. 10 for its Q4 and full-year earnings release and investor call. CEO-elect Henrique Braun and CFO John Murphy will speak at the CAGNY conference in Orlando on Feb. 17. Coke expects a $1 billion impairment charge in Q4 tied to its Africa bottling sale. PepsiCo shares gained 1.4% while the S&P 500 ETF slipped 0.4%.
13 January 2026
··
American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines shares fell 3.5% to $15.44 Tuesday, underperforming other major U.S. carriers as investors reacted to Delta’s profit forecast and concerns over a proposed 10% cap on credit-card interest rates. The cap could threaten airline loyalty program profits. American will report earnings Jan. 27, the same day the NTSB holds a hearing on a 2025 fatal crash involving one of its regional jets.
13 January 2026
·····
1 … 665 666 667 668 669 … 1,883

Stock Market Today

  • Nifty 50 Faces Geopolitical Risks Amid Bullish Technical Setup
    April 30, 2026, 5:04 AM EDT. Indian stock index Nifty 50 shows a bullish flag pattern indicating potential upside but struggles near 24,300-24,400 resistance. The market juggles strong corporate earnings against rising crude prices above $121/barrel due to the blocked Strait of Hormuz amid U.S.-Iran tensions. With India importing 88% of its oil, energy cost pressures weigh heavily. Analysts warn of a "geopolitical minefield" threatening sharp declines if the energy crisis intensifies. The index hovers near its 50-day Moving Average, a key trend signal. Univest analyst Ankit Jaiswal suggests sustaining above 24,177 in the early trading session is crucial to avoid a bearish trap leading to a fall toward 23,900.

Latest article

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

30 April 2026
Australian shares fell for an eighth straight session Thursday, with the S&P/ASX 200 closing down 0.24% at 8,665.8 as miners and consumer staples dropped. The decline followed data showing annual inflation rose to 4.6% in March, above the Reserve Bank’s target. Woolworths shares slid up to 9.8% after warning on earnings. Oil prices hit a four-year high, lifting energy stocks 1.4%.
Go toTop